+关注
lih
暂无个人介绍
IP属地:未知
269
关注
7
粉丝
0
主题
0
勋章
主贴
热门
lih
2021-12-03
ok
@B.God:
$BlackBerry(BB)$
Institutions flushed out the weak idiot hands and stole their shares cheap after these weak idiots cut loss yesterday. 🤡
lih
2021-10-08
Like
China tech names rally in morning trading
lih
2021-10-06
Like
Merck May Beat Pfizer to the COVID Pill Market. Does It Matter?
lih
2021-10-05
Ok
抱歉,原内容已删除
lih
2021-10-04
Ok
抱歉,原内容已删除
lih
2021-09-26
Great ariticle, would you like to share it?
China Declares Cryptocurrency-Related Activities Illegal
lih
2021-09-17
Ok
Why Palantir Shares Are Trading Higher Today
lih
2021-09-17
Ok
Why Palantir Shares Are Trading Higher Today
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"4094203859093810","uuid":"4094203859093810","gmtCreate":1631101309012,"gmtModify":1632552224091,"name":"lih","pinyin":"lih","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/71ace79439d0a5f0966a7046aa609708","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":7,"headSize":269,"tweetSize":8,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖(非转发)","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"60.31%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":3,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":601902855,"gmtCreate":1638468538277,"gmtModify":1638468538341,"author":{"id":"4094203859093810","authorId":"4094203859093810","name":"lih","avatar":"https://static.tigerbbs.com/71ace79439d0a5f0966a7046aa609708","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094203859093810","authorIdStr":"4094203859093810"},"themes":[],"htmlText":"ok","listText":"ok","text":"ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/601902855","repostId":"601017850","repostType":1,"repost":{"id":601017850,"gmtCreate":1638459363567,"gmtModify":1638494959903,"author":{"id":"3574968450404111","authorId":"3574968450404111","name":"B.God","avatar":"https://static.tigerbbs.com/8fba96cdefc2640a0413c00996aed28d","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574968450404111","authorIdStr":"3574968450404111"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BB\">$BlackBerry(BB)$</a>Institutions flushed out the weak idiot hands and stole their shares cheap after these weak idiots cut loss yesterday. 🤡","listText":"<a href=\"https://laohu8.com/S/BB\">$BlackBerry(BB)$</a>Institutions flushed out the weak idiot hands and stole their shares cheap after these weak idiots cut loss yesterday. 🤡","text":"$BlackBerry(BB)$Institutions flushed out the weak idiot hands and stole their shares cheap after these weak idiots cut loss yesterday. 🤡","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/601017850","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":1,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":961,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":823412111,"gmtCreate":1633654097355,"gmtModify":1633654146169,"author":{"id":"4094203859093810","authorId":"4094203859093810","name":"lih","avatar":"https://static.tigerbbs.com/71ace79439d0a5f0966a7046aa609708","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094203859093810","authorIdStr":"4094203859093810"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/823412111","repostId":"1170144488","repostType":4,"repost":{"id":"1170144488","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1633614175,"share":"https://ttm.financial/m/news/1170144488?lang=&edition=full","pubTime":"2021-10-07 21:42","market":"other","language":"en","title":"China tech names rally in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1170144488","media":"Tiger Newspress","summary":"(Oct 7) China tech names rally in morning trading.\n\nChinese technology stocks listed in the U.S. are","content":"<p>(Oct 7) China tech names rally in morning trading.</p>\n<p><img src=\"https://static.tigerbbs.com/82f43fe405c7a1e296adb418a0267dda\" tg-width=\"343\" tg-height=\"843\" referrerpolicy=\"no-referrer\"></p>\n<p>Chinese technology stocks listed in the U.S. are signaling a third day of gains in moring trading after peers in Asia rallied on improved risk appetite.</p>\n<p>Shares in Pinduoduo Inc. rose 4.6% as of 9:44 a.m. in New York, while Alibaba Group Holding Ltd. climbed 5.67%. Other technology shares including Baidu Inc., Bilibili Inc. and DiDi Global Inc. were among American depositary receipts rising.</p>\n<p>Chinese technology stocks rebounded from a record low in Hong Kong on Thursday amid signs of renewed interest in one of China’s biggest tech names. Charlie Munger’s Daily Journal Corp. was reported to have increased its Alibaba stake by 83% last quarter.</p>\n<p><img src=\"https://static.tigerbbs.com/21da2b3e7cd8ae63e949304ad3076747\" tg-width=\"1200\" tg-height=\"675\" referrerpolicy=\"no-referrer\">The Nasdaq Golden Dragon China Index -- which tracks several firms listed in the U.S. that conduct a majority of their business in China -- has also climbed for the past two days. Yet despite this week’s brief respite, the gauge remains deeply in the red year-to-date, having fallen 35%.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China tech names rally in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina tech names rally in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-10-07 21:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Oct 7) China tech names rally in morning trading.</p>\n<p><img src=\"https://static.tigerbbs.com/82f43fe405c7a1e296adb418a0267dda\" tg-width=\"343\" tg-height=\"843\" referrerpolicy=\"no-referrer\"></p>\n<p>Chinese technology stocks listed in the U.S. are signaling a third day of gains in moring trading after peers in Asia rallied on improved risk appetite.</p>\n<p>Shares in Pinduoduo Inc. rose 4.6% as of 9:44 a.m. in New York, while Alibaba Group Holding Ltd. climbed 5.67%. Other technology shares including Baidu Inc., Bilibili Inc. and DiDi Global Inc. were among American depositary receipts rising.</p>\n<p>Chinese technology stocks rebounded from a record low in Hong Kong on Thursday amid signs of renewed interest in one of China’s biggest tech names. Charlie Munger’s Daily Journal Corp. was reported to have increased its Alibaba stake by 83% last quarter.</p>\n<p><img src=\"https://static.tigerbbs.com/21da2b3e7cd8ae63e949304ad3076747\" tg-width=\"1200\" tg-height=\"675\" referrerpolicy=\"no-referrer\">The Nasdaq Golden Dragon China Index -- which tracks several firms listed in the U.S. that conduct a majority of their business in China -- has also climbed for the past two days. Yet despite this week’s brief respite, the gauge remains deeply in the red year-to-date, having fallen 35%.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1170144488","content_text":"(Oct 7) China tech names rally in morning trading.\n\nChinese technology stocks listed in the U.S. are signaling a third day of gains in moring trading after peers in Asia rallied on improved risk appetite.\nShares in Pinduoduo Inc. rose 4.6% as of 9:44 a.m. in New York, while Alibaba Group Holding Ltd. climbed 5.67%. Other technology shares including Baidu Inc., Bilibili Inc. and DiDi Global Inc. were among American depositary receipts rising.\nChinese technology stocks rebounded from a record low in Hong Kong on Thursday amid signs of renewed interest in one of China’s biggest tech names. Charlie Munger’s Daily Journal Corp. was reported to have increased its Alibaba stake by 83% last quarter.\nThe Nasdaq Golden Dragon China Index -- which tracks several firms listed in the U.S. that conduct a majority of their business in China -- has also climbed for the past two days. Yet despite this week’s brief respite, the gauge remains deeply in the red year-to-date, having fallen 35%.","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":2028,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":829258732,"gmtCreate":1633519104612,"gmtModify":1633519104765,"author":{"id":"4094203859093810","authorId":"4094203859093810","name":"lih","avatar":"https://static.tigerbbs.com/71ace79439d0a5f0966a7046aa609708","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094203859093810","authorIdStr":"4094203859093810"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/829258732","repostId":"2173791278","repostType":4,"repost":{"id":"2173791278","kind":"highlight","pubTimestamp":1633518240,"share":"https://ttm.financial/m/news/2173791278?lang=&edition=full","pubTime":"2021-10-06 19:04","market":"us","language":"en","title":"Merck May Beat Pfizer to the COVID Pill Market. Does It Matter?","url":"https://stock-news.laohu8.com/highlight/detail?id=2173791278","media":"Motley Fool","summary":"Merck is ready to apply for authorization ahead of Pfizer.","content":"<p>Big pharma companies <b>Merck</b> (NYSE:MRK) and <b>Pfizer</b> (NYSE:PFE) have been neck and neck in the most recent coronavirus race: the race to develop a pill to fight the virus. Pfizer has drawn a lot of attention due to its leadership in the coronavirus vaccine market. The idea has been this: If Pfizer brings the first pill to market, the company can dominate in prevention <i>and</i> treatment.</p>\n<p>Merck may have burst that Pfizer dream last week though. Merck reported strong data from trials of its investigational covid pill -- and said it would request emergency authorization as soon as possible. Pfizer said back in July it would report data from its trial in the fourth quarter. Of course, that could be at any point as of now. Still, it's clear Merck is a step ahead from a timeline perspective. Let's take a closer look at what this means for Pfizer and its shareholders.</p>\n<p><img src=\"https://static.tigerbbs.com/deb314918168b875dda34357715f22fa\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>Image source: Getty Images.</p>\n<h3>The covid treatment market</h3>\n<p>First, a quick look at the treatment market. Right now, options are limited. The U.S. Food and Drug Administration has approved <b>Gilead Sciences'</b> Veklury (remdesivir) -- an antiviral administered to hospitalized patients through infusion. And the regulatory agency has authorized monoclonal antibody treatments. These are meant for at-risk individuals with mild-to-moderate illness. They're given through infusion in a healthcare setting.</p>\n<p>So far, though, there hasn't been a pill option that people can take on their own. Several companies are working on possibilities. But Merck and Pfizer have remained at the head of the pack. At least when it comes to timing.</p>\n<p>A pill could be a game-changer. That's because it can be administered quickly and easily outside of a healthcare setting. People may be more likely to agree to take a pill at home than to make an appointment for an infusion. A pill also is a game-changer because it may halt the illness before it wreaks havoc. And that means fewer people will end up in the hospital.</p>\n<p>Pills also offer a storage advantage. It's much easier for countries to stockpile pills than products needing more space or specific temperatures.</p>\n<h3>Peak sales of $5 billion</h3>\n<p>So, it's clear pills could be big. SVB Leerink analyst Daina Graybosch predicts the Merck pill -- molnupiravir -- could generate peak annual sales of about $5 billion next year, according to <i>Stat News</i>. But does this first-to-market position mean bad news for Pfizer? Not necessarily.</p>\n<p>Of course, it's ideal to be first to market. If your product works well, it's likely people will stick with it. But, as we've seen with the coronavirus vaccine market, there is room for more than <a href=\"https://laohu8.com/S/AONE.U\">one</a> player. I think this will be the case in the treatment market as well. First, there's the idea of production and delivery. One company will have difficulty supplying the entire world.</p>\n<p>Second, there's the idea of product profile and efficacy. Merck's molnupiravir trips up the virus' ability to replicate properly. That's why it must be given within the first few days of infection -- before extensive replication has happened. Pfizer's investigational pill also blocks viral replication and must be given early on. But it works in a different way than molnupiravir. It stops protease enzymes from doing their job. Potentially, doctors may decide that one of the drugs is better for some patients and the other is best for other patients. Or studies may show positive results when combining the treatments.</p>\n<p>Molnupiravir reduced the risk of hospitalization or death by 50% compared with placebo in phase 3 trials. This is very positive. But we don't yet have Pfizer's data. If Pfizer results are about the same, it's likely the companies can share the treatment market. However, if Pfizer's results are much better or not as good, the whole picture could change.</p>\n<h3>What does this mean for Pfizer investors?</h3>\n<p>So, what does this mean for Pfizer and its investors? Pfizer won't lose out if it makes it to market after Merck. What will determine Pfizer's market share potential will be the data. It's important for Pfizer investors to keep an eye on that news -- and eventually compare the Pfizer results to those of Merck's investigational pill.</p>\n<p>In any case, though, Pfizer investors shouldn't worry. The company leads the global coronavirus vaccine market. Including the coronavirus vaccine, Pfizer sells eight blockbuster products and has 100 projects in the pipeline. Dominance in the coronavirus pill market would be great. But if it doesn't happen, there are still plenty of reasons to hang onto this pharmaceutical stock for the long term.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Merck May Beat Pfizer to the COVID Pill Market. Does It Matter?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMerck May Beat Pfizer to the COVID Pill Market. Does It Matter?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-06 19:04 GMT+8 <a href=https://www.fool.com/investing/2021/10/06/merck-may-beat-pfizer-to-the-covid-pill-market-doe/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Big pharma companies Merck (NYSE:MRK) and Pfizer (NYSE:PFE) have been neck and neck in the most recent coronavirus race: the race to develop a pill to fight the virus. Pfizer has drawn a lot of ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/10/06/merck-may-beat-pfizer-to-the-covid-pill-market-doe/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","MRK":"默沙东"},"source_url":"https://www.fool.com/investing/2021/10/06/merck-may-beat-pfizer-to-the-covid-pill-market-doe/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2173791278","content_text":"Big pharma companies Merck (NYSE:MRK) and Pfizer (NYSE:PFE) have been neck and neck in the most recent coronavirus race: the race to develop a pill to fight the virus. Pfizer has drawn a lot of attention due to its leadership in the coronavirus vaccine market. The idea has been this: If Pfizer brings the first pill to market, the company can dominate in prevention and treatment.\nMerck may have burst that Pfizer dream last week though. Merck reported strong data from trials of its investigational covid pill -- and said it would request emergency authorization as soon as possible. Pfizer said back in July it would report data from its trial in the fourth quarter. Of course, that could be at any point as of now. Still, it's clear Merck is a step ahead from a timeline perspective. Let's take a closer look at what this means for Pfizer and its shareholders.\n\nImage source: Getty Images.\nThe covid treatment market\nFirst, a quick look at the treatment market. Right now, options are limited. The U.S. Food and Drug Administration has approved Gilead Sciences' Veklury (remdesivir) -- an antiviral administered to hospitalized patients through infusion. And the regulatory agency has authorized monoclonal antibody treatments. These are meant for at-risk individuals with mild-to-moderate illness. They're given through infusion in a healthcare setting.\nSo far, though, there hasn't been a pill option that people can take on their own. Several companies are working on possibilities. But Merck and Pfizer have remained at the head of the pack. At least when it comes to timing.\nA pill could be a game-changer. That's because it can be administered quickly and easily outside of a healthcare setting. People may be more likely to agree to take a pill at home than to make an appointment for an infusion. A pill also is a game-changer because it may halt the illness before it wreaks havoc. And that means fewer people will end up in the hospital.\nPills also offer a storage advantage. It's much easier for countries to stockpile pills than products needing more space or specific temperatures.\nPeak sales of $5 billion\nSo, it's clear pills could be big. SVB Leerink analyst Daina Graybosch predicts the Merck pill -- molnupiravir -- could generate peak annual sales of about $5 billion next year, according to Stat News. But does this first-to-market position mean bad news for Pfizer? Not necessarily.\nOf course, it's ideal to be first to market. If your product works well, it's likely people will stick with it. But, as we've seen with the coronavirus vaccine market, there is room for more than one player. I think this will be the case in the treatment market as well. First, there's the idea of production and delivery. One company will have difficulty supplying the entire world.\nSecond, there's the idea of product profile and efficacy. Merck's molnupiravir trips up the virus' ability to replicate properly. That's why it must be given within the first few days of infection -- before extensive replication has happened. Pfizer's investigational pill also blocks viral replication and must be given early on. But it works in a different way than molnupiravir. It stops protease enzymes from doing their job. Potentially, doctors may decide that one of the drugs is better for some patients and the other is best for other patients. Or studies may show positive results when combining the treatments.\nMolnupiravir reduced the risk of hospitalization or death by 50% compared with placebo in phase 3 trials. This is very positive. But we don't yet have Pfizer's data. If Pfizer results are about the same, it's likely the companies can share the treatment market. However, if Pfizer's results are much better or not as good, the whole picture could change.\nWhat does this mean for Pfizer investors?\nSo, what does this mean for Pfizer and its investors? Pfizer won't lose out if it makes it to market after Merck. What will determine Pfizer's market share potential will be the data. It's important for Pfizer investors to keep an eye on that news -- and eventually compare the Pfizer results to those of Merck's investigational pill.\nIn any case, though, Pfizer investors shouldn't worry. The company leads the global coronavirus vaccine market. Including the coronavirus vaccine, Pfizer sells eight blockbuster products and has 100 projects in the pipeline. Dominance in the coronavirus pill market would be great. But if it doesn't happen, there are still plenty of reasons to hang onto this pharmaceutical stock for the long term.","news_type":1,"symbols_score_info":{"MRK":0.9,"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":2273,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":820518075,"gmtCreate":1633401505603,"gmtModify":1633401505724,"author":{"id":"4094203859093810","authorId":"4094203859093810","name":"lih","avatar":"https://static.tigerbbs.com/71ace79439d0a5f0966a7046aa609708","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094203859093810","authorIdStr":"4094203859093810"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/820518075","repostId":"1121300578","repostType":4,"isVote":1,"tweetType":1,"viewCount":2207,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":820136696,"gmtCreate":1633357804246,"gmtModify":1633357853747,"author":{"id":"4094203859093810","authorId":"4094203859093810","name":"lih","avatar":"https://static.tigerbbs.com/71ace79439d0a5f0966a7046aa609708","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094203859093810","authorIdStr":"4094203859093810"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/820136696","repostId":"2172996449","repostType":4,"isVote":1,"tweetType":1,"viewCount":1850,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":868104116,"gmtCreate":1632617174635,"gmtModify":1632652372443,"author":{"id":"4094203859093810","authorId":"4094203859093810","name":"lih","avatar":"https://static.tigerbbs.com/71ace79439d0a5f0966a7046aa609708","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094203859093810","authorIdStr":"4094203859093810"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/868104116","repostId":"2170611891","repostType":4,"repost":{"id":"2170611891","kind":"highlight","weMediaInfo":{"introduction":"新型财经科技信息服务提供商,专注TMT。技术改变商业,商业改变世界,我们纪录这个过程,并聚集这些改变世界的人。","home_visible":1,"media_name":"TMTPost","id":"1065587721","head_image":"https://static.tigerbbs.com/72948639b39fd795a430fcaa2772851c"},"pubTimestamp":1632526620,"share":"https://ttm.financial/m/news/2170611891?lang=&edition=full","pubTime":"2021-09-25 07:37","market":"hk","language":"en","title":"China Declares Cryptocurrency-Related Activities Illegal","url":"https://stock-news.laohu8.com/highlight/detail?id=2170611891","media":"TMTPost","summary":"BEIJING, September 23 (TMTPOST) — The People's Bank of China, the country’s central bank, has releas","content":"<p>BEIJING, September 23 (TMTPOST) — The People's Bank of China, the country’s central bank, has released the Notice on Further Regulating and Preventing Risks Posed by Cryptocurrency Transactions, which stresses that cryptocurrency-related activities are illegal financial activities.</p>\n<p>According to the notice, cryptocurrency does not enjoy the legal status that fiat money has. Cryptocurrencies are decentralized digital money based on blockchain technology. They are not issued by the authority and therefore do not enjoy the legal recognition that fiat money has. Cryptocurrencies should not be used as money in the market and enter circulation. Financial activities that involve cryptocurrencies are all illegal activities, the central bank stated in the notice. Financial services that facilitate the exchange between cryptocurrency and fiat money, exchange of information on cryptocurrency trading, pricing of cryptocurrency, trading of cryptocurrency derivatives, and financing through cryptocurrency are forbidden and considered illegal. Criminal liabilities can be imposed if relevant violations constitute a criminal offense.</p>\n<p>The notice also states that it is also considered an illegal financial activity for overseas cryptocurrency exchange organizations to provide exchange services through the Internet for residents within China. Employees of such overseas exchange organizations who knowingly engage in cryptocurrency services and provide services on the marketing of cryptocurrency, payment, and technical support are punishable by law.</p>\n<p>The notice calls for more efforts in establishing a working mechanism in response to cryptocurrency trading as well. The notice states that it is important to establish coordination between government departments, and between the central government and local governments to monitor cryptocurrency activities.</p>\n<p>In addition, a risk forecast on cryptocurrency trading should be built, according to the notice. The central bank and the Cyberspace Administration of China should optimize their monitoring technology that targets cryptocurrency activities. Financial institutions and non-bank payment organizations should also enhance their efforts in monitoring cryptocurrency activities.</p>\n<p>Lastly, the notice calls for the development of a multi-level mechanism to prevent cryptocurrency trading and enforce relevant laws and regulations. The multi-level mechanism should involve financial management departments, telecom departments, law enforcement, and market regulators, etc.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China Declares Cryptocurrency-Related Activities Illegal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina Declares Cryptocurrency-Related Activities Illegal\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1065587721\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/72948639b39fd795a430fcaa2772851c);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">TMTPost </p>\n<p class=\"h-time\">2021-09-25 07:37</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BEIJING, September 23 (TMTPOST) — The People's Bank of China, the country’s central bank, has released the Notice on Further Regulating and Preventing Risks Posed by Cryptocurrency Transactions, which stresses that cryptocurrency-related activities are illegal financial activities.</p>\n<p>According to the notice, cryptocurrency does not enjoy the legal status that fiat money has. Cryptocurrencies are decentralized digital money based on blockchain technology. They are not issued by the authority and therefore do not enjoy the legal recognition that fiat money has. Cryptocurrencies should not be used as money in the market and enter circulation. Financial activities that involve cryptocurrencies are all illegal activities, the central bank stated in the notice. Financial services that facilitate the exchange between cryptocurrency and fiat money, exchange of information on cryptocurrency trading, pricing of cryptocurrency, trading of cryptocurrency derivatives, and financing through cryptocurrency are forbidden and considered illegal. Criminal liabilities can be imposed if relevant violations constitute a criminal offense.</p>\n<p>The notice also states that it is also considered an illegal financial activity for overseas cryptocurrency exchange organizations to provide exchange services through the Internet for residents within China. Employees of such overseas exchange organizations who knowingly engage in cryptocurrency services and provide services on the marketing of cryptocurrency, payment, and technical support are punishable by law.</p>\n<p>The notice calls for more efforts in establishing a working mechanism in response to cryptocurrency trading as well. The notice states that it is important to establish coordination between government departments, and between the central government and local governments to monitor cryptocurrency activities.</p>\n<p>In addition, a risk forecast on cryptocurrency trading should be built, according to the notice. The central bank and the Cyberspace Administration of China should optimize their monitoring technology that targets cryptocurrency activities. Financial institutions and non-bank payment organizations should also enhance their efforts in monitoring cryptocurrency activities.</p>\n<p>Lastly, the notice calls for the development of a multi-level mechanism to prevent cryptocurrency trading and enforce relevant laws and regulations. The multi-level mechanism should involve financial management departments, telecom departments, law enforcement, and market regulators, etc.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2170611891","content_text":"BEIJING, September 23 (TMTPOST) — The People's Bank of China, the country’s central bank, has released the Notice on Further Regulating and Preventing Risks Posed by Cryptocurrency Transactions, which stresses that cryptocurrency-related activities are illegal financial activities.\nAccording to the notice, cryptocurrency does not enjoy the legal status that fiat money has. Cryptocurrencies are decentralized digital money based on blockchain technology. They are not issued by the authority and therefore do not enjoy the legal recognition that fiat money has. Cryptocurrencies should not be used as money in the market and enter circulation. Financial activities that involve cryptocurrencies are all illegal activities, the central bank stated in the notice. Financial services that facilitate the exchange between cryptocurrency and fiat money, exchange of information on cryptocurrency trading, pricing of cryptocurrency, trading of cryptocurrency derivatives, and financing through cryptocurrency are forbidden and considered illegal. Criminal liabilities can be imposed if relevant violations constitute a criminal offense.\nThe notice also states that it is also considered an illegal financial activity for overseas cryptocurrency exchange organizations to provide exchange services through the Internet for residents within China. Employees of such overseas exchange organizations who knowingly engage in cryptocurrency services and provide services on the marketing of cryptocurrency, payment, and technical support are punishable by law.\nThe notice calls for more efforts in establishing a working mechanism in response to cryptocurrency trading as well. The notice states that it is important to establish coordination between government departments, and between the central government and local governments to monitor cryptocurrency activities.\nIn addition, a risk forecast on cryptocurrency trading should be built, according to the notice. The central bank and the Cyberspace Administration of China should optimize their monitoring technology that targets cryptocurrency activities. Financial institutions and non-bank payment organizations should also enhance their efforts in monitoring cryptocurrency activities.\nLastly, the notice calls for the development of a multi-level mechanism to prevent cryptocurrency trading and enforce relevant laws and regulations. The multi-level mechanism should involve financial management departments, telecom departments, law enforcement, and market regulators, etc.","news_type":1,"symbols_score_info":{"CAAS":0.9}},"isVote":1,"tweetType":1,"viewCount":1979,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":884063412,"gmtCreate":1631840357936,"gmtModify":1632805869000,"author":{"id":"4094203859093810","authorId":"4094203859093810","name":"lih","avatar":"https://static.tigerbbs.com/71ace79439d0a5f0966a7046aa609708","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094203859093810","authorIdStr":"4094203859093810"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/884063412","repostId":"1187895428","repostType":4,"repost":{"id":"1187895428","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1631805240,"share":"https://ttm.financial/m/news/1187895428?lang=&edition=full","pubTime":"2021-09-16 23:14","market":"us","language":"en","title":"Why Palantir Shares Are Trading Higher Today","url":"https://stock-news.laohu8.com/highlight/detail?id=1187895428","media":"Benzinga","summary":"Palantir Technologies is trading higher Thursday morning on above-average volume amid increased retail investor interest in the stock on social media.The average session volume is about 42 million over a 100-day period. Palantir's daily trading volume was already approaching 30 million less than an hour into trading Thursday.Palantir was one the top two trending stocks on Stocktwits at publication time. The stock was among the top five most mentioned stocks on the subreddit r/wallstreetbets over","content":"<p><b>Palantir Technologies</b> is trading higher Thursday morning on above-average volume amid increased retail investor interest in the stock on social media.</p>\n<p><img src=\"https://static.tigerbbs.com/8ab0249e536a33b1fd6c306c047556b8\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p>\n<p>The average session volume is about 42 million over a 100-day period. Palantir's daily trading volume was already approaching 30 million less than an hour into trading Thursday.</p>\n<p>Palantir was one the top two trending stocks on Stocktwits at publication time. The stock was among the top five most mentioned stocks on the subreddit r/wallstreetbets over the last 24 hours.</p>\n<p>Palantir has continually said that it expects revenue growth of 30% or greater through 2025.</p>\n<p>The company makes products for human-driven analysis of real-world data.</p>\n<p><b>PLTR Price Action:</b>Palantir has traded as high as $45 and as low as $8.90 over a 52-week period.</p>\n<p>The stock was up 5% at $28.45 at time of publication.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Palantir Shares Are Trading Higher Today</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Palantir Shares Are Trading Higher Today\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-09-16 23:14</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>Palantir Technologies</b> is trading higher Thursday morning on above-average volume amid increased retail investor interest in the stock on social media.</p>\n<p><img src=\"https://static.tigerbbs.com/8ab0249e536a33b1fd6c306c047556b8\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p>\n<p>The average session volume is about 42 million over a 100-day period. Palantir's daily trading volume was already approaching 30 million less than an hour into trading Thursday.</p>\n<p>Palantir was one the top two trending stocks on Stocktwits at publication time. The stock was among the top five most mentioned stocks on the subreddit r/wallstreetbets over the last 24 hours.</p>\n<p>Palantir has continually said that it expects revenue growth of 30% or greater through 2025.</p>\n<p>The company makes products for human-driven analysis of real-world data.</p>\n<p><b>PLTR Price Action:</b>Palantir has traded as high as $45 and as low as $8.90 over a 52-week period.</p>\n<p>The stock was up 5% at $28.45 at time of publication.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1187895428","content_text":"Palantir Technologies is trading higher Thursday morning on above-average volume amid increased retail investor interest in the stock on social media.\n\nThe average session volume is about 42 million over a 100-day period. Palantir's daily trading volume was already approaching 30 million less than an hour into trading Thursday.\nPalantir was one the top two trending stocks on Stocktwits at publication time. The stock was among the top five most mentioned stocks on the subreddit r/wallstreetbets over the last 24 hours.\nPalantir has continually said that it expects revenue growth of 30% or greater through 2025.\nThe company makes products for human-driven analysis of real-world data.\nPLTR Price Action:Palantir has traded as high as $45 and as low as $8.90 over a 52-week period.\nThe stock was up 5% at $28.45 at time of publication.","news_type":1,"symbols_score_info":{"PLTR":0.9}},"isVote":1,"tweetType":1,"viewCount":868,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":884069590,"gmtCreate":1631840316710,"gmtModify":1632805870034,"author":{"id":"4094203859093810","authorId":"4094203859093810","name":"lih","avatar":"https://static.tigerbbs.com/71ace79439d0a5f0966a7046aa609708","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094203859093810","authorIdStr":"4094203859093810"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/884069590","repostId":"1187895428","repostType":4,"repost":{"id":"1187895428","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1631805240,"share":"https://ttm.financial/m/news/1187895428?lang=&edition=full","pubTime":"2021-09-16 23:14","market":"us","language":"en","title":"Why Palantir Shares Are Trading Higher Today","url":"https://stock-news.laohu8.com/highlight/detail?id=1187895428","media":"Benzinga","summary":"Palantir Technologies is trading higher Thursday morning on above-average volume amid increased retail investor interest in the stock on social media.The average session volume is about 42 million over a 100-day period. Palantir's daily trading volume was already approaching 30 million less than an hour into trading Thursday.Palantir was one the top two trending stocks on Stocktwits at publication time. The stock was among the top five most mentioned stocks on the subreddit r/wallstreetbets over","content":"<p><b>Palantir Technologies</b> is trading higher Thursday morning on above-average volume amid increased retail investor interest in the stock on social media.</p>\n<p><img src=\"https://static.tigerbbs.com/8ab0249e536a33b1fd6c306c047556b8\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p>\n<p>The average session volume is about 42 million over a 100-day period. Palantir's daily trading volume was already approaching 30 million less than an hour into trading Thursday.</p>\n<p>Palantir was one the top two trending stocks on Stocktwits at publication time. The stock was among the top five most mentioned stocks on the subreddit r/wallstreetbets over the last 24 hours.</p>\n<p>Palantir has continually said that it expects revenue growth of 30% or greater through 2025.</p>\n<p>The company makes products for human-driven analysis of real-world data.</p>\n<p><b>PLTR Price Action:</b>Palantir has traded as high as $45 and as low as $8.90 over a 52-week period.</p>\n<p>The stock was up 5% at $28.45 at time of publication.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Palantir Shares Are Trading Higher Today</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Palantir Shares Are Trading Higher Today\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-09-16 23:14</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>Palantir Technologies</b> is trading higher Thursday morning on above-average volume amid increased retail investor interest in the stock on social media.</p>\n<p><img src=\"https://static.tigerbbs.com/8ab0249e536a33b1fd6c306c047556b8\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p>\n<p>The average session volume is about 42 million over a 100-day period. Palantir's daily trading volume was already approaching 30 million less than an hour into trading Thursday.</p>\n<p>Palantir was one the top two trending stocks on Stocktwits at publication time. The stock was among the top five most mentioned stocks on the subreddit r/wallstreetbets over the last 24 hours.</p>\n<p>Palantir has continually said that it expects revenue growth of 30% or greater through 2025.</p>\n<p>The company makes products for human-driven analysis of real-world data.</p>\n<p><b>PLTR Price Action:</b>Palantir has traded as high as $45 and as low as $8.90 over a 52-week period.</p>\n<p>The stock was up 5% at $28.45 at time of publication.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1187895428","content_text":"Palantir Technologies is trading higher Thursday morning on above-average volume amid increased retail investor interest in the stock on social media.\n\nThe average session volume is about 42 million over a 100-day period. Palantir's daily trading volume was already approaching 30 million less than an hour into trading Thursday.\nPalantir was one the top two trending stocks on Stocktwits at publication time. The stock was among the top five most mentioned stocks on the subreddit r/wallstreetbets over the last 24 hours.\nPalantir has continually said that it expects revenue growth of 30% or greater through 2025.\nThe company makes products for human-driven analysis of real-world data.\nPLTR Price Action:Palantir has traded as high as $45 and as low as $8.90 over a 52-week period.\nThe stock was up 5% at $28.45 at time of publication.","news_type":1,"symbols_score_info":{"PLTR":0.9}},"isVote":1,"tweetType":1,"viewCount":692,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":820136696,"gmtCreate":1633357804246,"gmtModify":1633357853747,"author":{"id":"4094203859093810","authorId":"4094203859093810","name":"lih","avatar":"https://static.tigerbbs.com/71ace79439d0a5f0966a7046aa609708","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094203859093810","authorIdStr":"4094203859093810"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/820136696","repostId":"2172996449","repostType":4,"isVote":1,"tweetType":1,"viewCount":1850,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":868104116,"gmtCreate":1632617174635,"gmtModify":1632652372443,"author":{"id":"4094203859093810","authorId":"4094203859093810","name":"lih","avatar":"https://static.tigerbbs.com/71ace79439d0a5f0966a7046aa609708","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094203859093810","authorIdStr":"4094203859093810"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/868104116","repostId":"2170611891","repostType":4,"repost":{"id":"2170611891","kind":"highlight","weMediaInfo":{"introduction":"新型财经科技信息服务提供商,专注TMT。技术改变商业,商业改变世界,我们纪录这个过程,并聚集这些改变世界的人。","home_visible":1,"media_name":"TMTPost","id":"1065587721","head_image":"https://static.tigerbbs.com/72948639b39fd795a430fcaa2772851c"},"pubTimestamp":1632526620,"share":"https://ttm.financial/m/news/2170611891?lang=&edition=full","pubTime":"2021-09-25 07:37","market":"hk","language":"en","title":"China Declares Cryptocurrency-Related Activities Illegal","url":"https://stock-news.laohu8.com/highlight/detail?id=2170611891","media":"TMTPost","summary":"BEIJING, September 23 (TMTPOST) — The People's Bank of China, the country’s central bank, has releas","content":"<p>BEIJING, September 23 (TMTPOST) — The People's Bank of China, the country’s central bank, has released the Notice on Further Regulating and Preventing Risks Posed by Cryptocurrency Transactions, which stresses that cryptocurrency-related activities are illegal financial activities.</p>\n<p>According to the notice, cryptocurrency does not enjoy the legal status that fiat money has. Cryptocurrencies are decentralized digital money based on blockchain technology. They are not issued by the authority and therefore do not enjoy the legal recognition that fiat money has. Cryptocurrencies should not be used as money in the market and enter circulation. Financial activities that involve cryptocurrencies are all illegal activities, the central bank stated in the notice. Financial services that facilitate the exchange between cryptocurrency and fiat money, exchange of information on cryptocurrency trading, pricing of cryptocurrency, trading of cryptocurrency derivatives, and financing through cryptocurrency are forbidden and considered illegal. Criminal liabilities can be imposed if relevant violations constitute a criminal offense.</p>\n<p>The notice also states that it is also considered an illegal financial activity for overseas cryptocurrency exchange organizations to provide exchange services through the Internet for residents within China. Employees of such overseas exchange organizations who knowingly engage in cryptocurrency services and provide services on the marketing of cryptocurrency, payment, and technical support are punishable by law.</p>\n<p>The notice calls for more efforts in establishing a working mechanism in response to cryptocurrency trading as well. The notice states that it is important to establish coordination between government departments, and between the central government and local governments to monitor cryptocurrency activities.</p>\n<p>In addition, a risk forecast on cryptocurrency trading should be built, according to the notice. The central bank and the Cyberspace Administration of China should optimize their monitoring technology that targets cryptocurrency activities. Financial institutions and non-bank payment organizations should also enhance their efforts in monitoring cryptocurrency activities.</p>\n<p>Lastly, the notice calls for the development of a multi-level mechanism to prevent cryptocurrency trading and enforce relevant laws and regulations. The multi-level mechanism should involve financial management departments, telecom departments, law enforcement, and market regulators, etc.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China Declares Cryptocurrency-Related Activities Illegal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina Declares Cryptocurrency-Related Activities Illegal\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1065587721\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/72948639b39fd795a430fcaa2772851c);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">TMTPost </p>\n<p class=\"h-time\">2021-09-25 07:37</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BEIJING, September 23 (TMTPOST) — The People's Bank of China, the country’s central bank, has released the Notice on Further Regulating and Preventing Risks Posed by Cryptocurrency Transactions, which stresses that cryptocurrency-related activities are illegal financial activities.</p>\n<p>According to the notice, cryptocurrency does not enjoy the legal status that fiat money has. Cryptocurrencies are decentralized digital money based on blockchain technology. They are not issued by the authority and therefore do not enjoy the legal recognition that fiat money has. Cryptocurrencies should not be used as money in the market and enter circulation. Financial activities that involve cryptocurrencies are all illegal activities, the central bank stated in the notice. Financial services that facilitate the exchange between cryptocurrency and fiat money, exchange of information on cryptocurrency trading, pricing of cryptocurrency, trading of cryptocurrency derivatives, and financing through cryptocurrency are forbidden and considered illegal. Criminal liabilities can be imposed if relevant violations constitute a criminal offense.</p>\n<p>The notice also states that it is also considered an illegal financial activity for overseas cryptocurrency exchange organizations to provide exchange services through the Internet for residents within China. Employees of such overseas exchange organizations who knowingly engage in cryptocurrency services and provide services on the marketing of cryptocurrency, payment, and technical support are punishable by law.</p>\n<p>The notice calls for more efforts in establishing a working mechanism in response to cryptocurrency trading as well. The notice states that it is important to establish coordination between government departments, and between the central government and local governments to monitor cryptocurrency activities.</p>\n<p>In addition, a risk forecast on cryptocurrency trading should be built, according to the notice. The central bank and the Cyberspace Administration of China should optimize their monitoring technology that targets cryptocurrency activities. Financial institutions and non-bank payment organizations should also enhance their efforts in monitoring cryptocurrency activities.</p>\n<p>Lastly, the notice calls for the development of a multi-level mechanism to prevent cryptocurrency trading and enforce relevant laws and regulations. The multi-level mechanism should involve financial management departments, telecom departments, law enforcement, and market regulators, etc.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2170611891","content_text":"BEIJING, September 23 (TMTPOST) — The People's Bank of China, the country’s central bank, has released the Notice on Further Regulating and Preventing Risks Posed by Cryptocurrency Transactions, which stresses that cryptocurrency-related activities are illegal financial activities.\nAccording to the notice, cryptocurrency does not enjoy the legal status that fiat money has. Cryptocurrencies are decentralized digital money based on blockchain technology. They are not issued by the authority and therefore do not enjoy the legal recognition that fiat money has. Cryptocurrencies should not be used as money in the market and enter circulation. Financial activities that involve cryptocurrencies are all illegal activities, the central bank stated in the notice. Financial services that facilitate the exchange between cryptocurrency and fiat money, exchange of information on cryptocurrency trading, pricing of cryptocurrency, trading of cryptocurrency derivatives, and financing through cryptocurrency are forbidden and considered illegal. Criminal liabilities can be imposed if relevant violations constitute a criminal offense.\nThe notice also states that it is also considered an illegal financial activity for overseas cryptocurrency exchange organizations to provide exchange services through the Internet for residents within China. Employees of such overseas exchange organizations who knowingly engage in cryptocurrency services and provide services on the marketing of cryptocurrency, payment, and technical support are punishable by law.\nThe notice calls for more efforts in establishing a working mechanism in response to cryptocurrency trading as well. The notice states that it is important to establish coordination between government departments, and between the central government and local governments to monitor cryptocurrency activities.\nIn addition, a risk forecast on cryptocurrency trading should be built, according to the notice. The central bank and the Cyberspace Administration of China should optimize their monitoring technology that targets cryptocurrency activities. Financial institutions and non-bank payment organizations should also enhance their efforts in monitoring cryptocurrency activities.\nLastly, the notice calls for the development of a multi-level mechanism to prevent cryptocurrency trading and enforce relevant laws and regulations. The multi-level mechanism should involve financial management departments, telecom departments, law enforcement, and market regulators, etc.","news_type":1,"symbols_score_info":{"CAAS":0.9}},"isVote":1,"tweetType":1,"viewCount":1979,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":884063412,"gmtCreate":1631840357936,"gmtModify":1632805869000,"author":{"id":"4094203859093810","authorId":"4094203859093810","name":"lih","avatar":"https://static.tigerbbs.com/71ace79439d0a5f0966a7046aa609708","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094203859093810","authorIdStr":"4094203859093810"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/884063412","repostId":"1187895428","repostType":4,"repost":{"id":"1187895428","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1631805240,"share":"https://ttm.financial/m/news/1187895428?lang=&edition=full","pubTime":"2021-09-16 23:14","market":"us","language":"en","title":"Why Palantir Shares Are Trading Higher Today","url":"https://stock-news.laohu8.com/highlight/detail?id=1187895428","media":"Benzinga","summary":"Palantir Technologies is trading higher Thursday morning on above-average volume amid increased retail investor interest in the stock on social media.The average session volume is about 42 million over a 100-day period. Palantir's daily trading volume was already approaching 30 million less than an hour into trading Thursday.Palantir was one the top two trending stocks on Stocktwits at publication time. The stock was among the top five most mentioned stocks on the subreddit r/wallstreetbets over","content":"<p><b>Palantir Technologies</b> is trading higher Thursday morning on above-average volume amid increased retail investor interest in the stock on social media.</p>\n<p><img src=\"https://static.tigerbbs.com/8ab0249e536a33b1fd6c306c047556b8\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p>\n<p>The average session volume is about 42 million over a 100-day period. Palantir's daily trading volume was already approaching 30 million less than an hour into trading Thursday.</p>\n<p>Palantir was one the top two trending stocks on Stocktwits at publication time. The stock was among the top five most mentioned stocks on the subreddit r/wallstreetbets over the last 24 hours.</p>\n<p>Palantir has continually said that it expects revenue growth of 30% or greater through 2025.</p>\n<p>The company makes products for human-driven analysis of real-world data.</p>\n<p><b>PLTR Price Action:</b>Palantir has traded as high as $45 and as low as $8.90 over a 52-week period.</p>\n<p>The stock was up 5% at $28.45 at time of publication.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Palantir Shares Are Trading Higher Today</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Palantir Shares Are Trading Higher Today\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-09-16 23:14</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>Palantir Technologies</b> is trading higher Thursday morning on above-average volume amid increased retail investor interest in the stock on social media.</p>\n<p><img src=\"https://static.tigerbbs.com/8ab0249e536a33b1fd6c306c047556b8\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p>\n<p>The average session volume is about 42 million over a 100-day period. Palantir's daily trading volume was already approaching 30 million less than an hour into trading Thursday.</p>\n<p>Palantir was one the top two trending stocks on Stocktwits at publication time. The stock was among the top five most mentioned stocks on the subreddit r/wallstreetbets over the last 24 hours.</p>\n<p>Palantir has continually said that it expects revenue growth of 30% or greater through 2025.</p>\n<p>The company makes products for human-driven analysis of real-world data.</p>\n<p><b>PLTR Price Action:</b>Palantir has traded as high as $45 and as low as $8.90 over a 52-week period.</p>\n<p>The stock was up 5% at $28.45 at time of publication.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1187895428","content_text":"Palantir Technologies is trading higher Thursday morning on above-average volume amid increased retail investor interest in the stock on social media.\n\nThe average session volume is about 42 million over a 100-day period. Palantir's daily trading volume was already approaching 30 million less than an hour into trading Thursday.\nPalantir was one the top two trending stocks on Stocktwits at publication time. The stock was among the top five most mentioned stocks on the subreddit r/wallstreetbets over the last 24 hours.\nPalantir has continually said that it expects revenue growth of 30% or greater through 2025.\nThe company makes products for human-driven analysis of real-world data.\nPLTR Price Action:Palantir has traded as high as $45 and as low as $8.90 over a 52-week period.\nThe stock was up 5% at $28.45 at time of publication.","news_type":1,"symbols_score_info":{"PLTR":0.9}},"isVote":1,"tweetType":1,"viewCount":868,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":884069590,"gmtCreate":1631840316710,"gmtModify":1632805870034,"author":{"id":"4094203859093810","authorId":"4094203859093810","name":"lih","avatar":"https://static.tigerbbs.com/71ace79439d0a5f0966a7046aa609708","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094203859093810","authorIdStr":"4094203859093810"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/884069590","repostId":"1187895428","repostType":4,"repost":{"id":"1187895428","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1631805240,"share":"https://ttm.financial/m/news/1187895428?lang=&edition=full","pubTime":"2021-09-16 23:14","market":"us","language":"en","title":"Why Palantir Shares Are Trading Higher Today","url":"https://stock-news.laohu8.com/highlight/detail?id=1187895428","media":"Benzinga","summary":"Palantir Technologies is trading higher Thursday morning on above-average volume amid increased retail investor interest in the stock on social media.The average session volume is about 42 million over a 100-day period. Palantir's daily trading volume was already approaching 30 million less than an hour into trading Thursday.Palantir was one the top two trending stocks on Stocktwits at publication time. The stock was among the top five most mentioned stocks on the subreddit r/wallstreetbets over","content":"<p><b>Palantir Technologies</b> is trading higher Thursday morning on above-average volume amid increased retail investor interest in the stock on social media.</p>\n<p><img src=\"https://static.tigerbbs.com/8ab0249e536a33b1fd6c306c047556b8\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p>\n<p>The average session volume is about 42 million over a 100-day period. Palantir's daily trading volume was already approaching 30 million less than an hour into trading Thursday.</p>\n<p>Palantir was one the top two trending stocks on Stocktwits at publication time. The stock was among the top five most mentioned stocks on the subreddit r/wallstreetbets over the last 24 hours.</p>\n<p>Palantir has continually said that it expects revenue growth of 30% or greater through 2025.</p>\n<p>The company makes products for human-driven analysis of real-world data.</p>\n<p><b>PLTR Price Action:</b>Palantir has traded as high as $45 and as low as $8.90 over a 52-week period.</p>\n<p>The stock was up 5% at $28.45 at time of publication.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Palantir Shares Are Trading Higher Today</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Palantir Shares Are Trading Higher Today\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-09-16 23:14</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>Palantir Technologies</b> is trading higher Thursday morning on above-average volume amid increased retail investor interest in the stock on social media.</p>\n<p><img src=\"https://static.tigerbbs.com/8ab0249e536a33b1fd6c306c047556b8\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p>\n<p>The average session volume is about 42 million over a 100-day period. Palantir's daily trading volume was already approaching 30 million less than an hour into trading Thursday.</p>\n<p>Palantir was one the top two trending stocks on Stocktwits at publication time. The stock was among the top five most mentioned stocks on the subreddit r/wallstreetbets over the last 24 hours.</p>\n<p>Palantir has continually said that it expects revenue growth of 30% or greater through 2025.</p>\n<p>The company makes products for human-driven analysis of real-world data.</p>\n<p><b>PLTR Price Action:</b>Palantir has traded as high as $45 and as low as $8.90 over a 52-week period.</p>\n<p>The stock was up 5% at $28.45 at time of publication.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1187895428","content_text":"Palantir Technologies is trading higher Thursday morning on above-average volume amid increased retail investor interest in the stock on social media.\n\nThe average session volume is about 42 million over a 100-day period. Palantir's daily trading volume was already approaching 30 million less than an hour into trading Thursday.\nPalantir was one the top two trending stocks on Stocktwits at publication time. The stock was among the top five most mentioned stocks on the subreddit r/wallstreetbets over the last 24 hours.\nPalantir has continually said that it expects revenue growth of 30% or greater through 2025.\nThe company makes products for human-driven analysis of real-world data.\nPLTR Price Action:Palantir has traded as high as $45 and as low as $8.90 over a 52-week period.\nThe stock was up 5% at $28.45 at time of publication.","news_type":1,"symbols_score_info":{"PLTR":0.9}},"isVote":1,"tweetType":1,"viewCount":692,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":823412111,"gmtCreate":1633654097355,"gmtModify":1633654146169,"author":{"id":"4094203859093810","authorId":"4094203859093810","name":"lih","avatar":"https://static.tigerbbs.com/71ace79439d0a5f0966a7046aa609708","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094203859093810","authorIdStr":"4094203859093810"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/823412111","repostId":"1170144488","repostType":4,"isVote":1,"tweetType":1,"viewCount":2028,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":829258732,"gmtCreate":1633519104612,"gmtModify":1633519104765,"author":{"id":"4094203859093810","authorId":"4094203859093810","name":"lih","avatar":"https://static.tigerbbs.com/71ace79439d0a5f0966a7046aa609708","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094203859093810","authorIdStr":"4094203859093810"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/829258732","repostId":"2173791278","repostType":4,"repost":{"id":"2173791278","kind":"highlight","pubTimestamp":1633518240,"share":"https://ttm.financial/m/news/2173791278?lang=&edition=full","pubTime":"2021-10-06 19:04","market":"us","language":"en","title":"Merck May Beat Pfizer to the COVID Pill Market. Does It Matter?","url":"https://stock-news.laohu8.com/highlight/detail?id=2173791278","media":"Motley Fool","summary":"Merck is ready to apply for authorization ahead of Pfizer.","content":"<p>Big pharma companies <b>Merck</b> (NYSE:MRK) and <b>Pfizer</b> (NYSE:PFE) have been neck and neck in the most recent coronavirus race: the race to develop a pill to fight the virus. Pfizer has drawn a lot of attention due to its leadership in the coronavirus vaccine market. The idea has been this: If Pfizer brings the first pill to market, the company can dominate in prevention <i>and</i> treatment.</p>\n<p>Merck may have burst that Pfizer dream last week though. Merck reported strong data from trials of its investigational covid pill -- and said it would request emergency authorization as soon as possible. Pfizer said back in July it would report data from its trial in the fourth quarter. Of course, that could be at any point as of now. Still, it's clear Merck is a step ahead from a timeline perspective. Let's take a closer look at what this means for Pfizer and its shareholders.</p>\n<p><img src=\"https://static.tigerbbs.com/deb314918168b875dda34357715f22fa\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>Image source: Getty Images.</p>\n<h3>The covid treatment market</h3>\n<p>First, a quick look at the treatment market. Right now, options are limited. The U.S. Food and Drug Administration has approved <b>Gilead Sciences'</b> Veklury (remdesivir) -- an antiviral administered to hospitalized patients through infusion. And the regulatory agency has authorized monoclonal antibody treatments. These are meant for at-risk individuals with mild-to-moderate illness. They're given through infusion in a healthcare setting.</p>\n<p>So far, though, there hasn't been a pill option that people can take on their own. Several companies are working on possibilities. But Merck and Pfizer have remained at the head of the pack. At least when it comes to timing.</p>\n<p>A pill could be a game-changer. That's because it can be administered quickly and easily outside of a healthcare setting. People may be more likely to agree to take a pill at home than to make an appointment for an infusion. A pill also is a game-changer because it may halt the illness before it wreaks havoc. And that means fewer people will end up in the hospital.</p>\n<p>Pills also offer a storage advantage. It's much easier for countries to stockpile pills than products needing more space or specific temperatures.</p>\n<h3>Peak sales of $5 billion</h3>\n<p>So, it's clear pills could be big. SVB Leerink analyst Daina Graybosch predicts the Merck pill -- molnupiravir -- could generate peak annual sales of about $5 billion next year, according to <i>Stat News</i>. But does this first-to-market position mean bad news for Pfizer? Not necessarily.</p>\n<p>Of course, it's ideal to be first to market. If your product works well, it's likely people will stick with it. But, as we've seen with the coronavirus vaccine market, there is room for more than <a href=\"https://laohu8.com/S/AONE.U\">one</a> player. I think this will be the case in the treatment market as well. First, there's the idea of production and delivery. One company will have difficulty supplying the entire world.</p>\n<p>Second, there's the idea of product profile and efficacy. Merck's molnupiravir trips up the virus' ability to replicate properly. That's why it must be given within the first few days of infection -- before extensive replication has happened. Pfizer's investigational pill also blocks viral replication and must be given early on. But it works in a different way than molnupiravir. It stops protease enzymes from doing their job. Potentially, doctors may decide that one of the drugs is better for some patients and the other is best for other patients. Or studies may show positive results when combining the treatments.</p>\n<p>Molnupiravir reduced the risk of hospitalization or death by 50% compared with placebo in phase 3 trials. This is very positive. But we don't yet have Pfizer's data. If Pfizer results are about the same, it's likely the companies can share the treatment market. However, if Pfizer's results are much better or not as good, the whole picture could change.</p>\n<h3>What does this mean for Pfizer investors?</h3>\n<p>So, what does this mean for Pfizer and its investors? Pfizer won't lose out if it makes it to market after Merck. What will determine Pfizer's market share potential will be the data. It's important for Pfizer investors to keep an eye on that news -- and eventually compare the Pfizer results to those of Merck's investigational pill.</p>\n<p>In any case, though, Pfizer investors shouldn't worry. The company leads the global coronavirus vaccine market. Including the coronavirus vaccine, Pfizer sells eight blockbuster products and has 100 projects in the pipeline. Dominance in the coronavirus pill market would be great. But if it doesn't happen, there are still plenty of reasons to hang onto this pharmaceutical stock for the long term.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Merck May Beat Pfizer to the COVID Pill Market. Does It Matter?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMerck May Beat Pfizer to the COVID Pill Market. Does It Matter?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-06 19:04 GMT+8 <a href=https://www.fool.com/investing/2021/10/06/merck-may-beat-pfizer-to-the-covid-pill-market-doe/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Big pharma companies Merck (NYSE:MRK) and Pfizer (NYSE:PFE) have been neck and neck in the most recent coronavirus race: the race to develop a pill to fight the virus. Pfizer has drawn a lot of ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/10/06/merck-may-beat-pfizer-to-the-covid-pill-market-doe/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","MRK":"默沙东"},"source_url":"https://www.fool.com/investing/2021/10/06/merck-may-beat-pfizer-to-the-covid-pill-market-doe/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2173791278","content_text":"Big pharma companies Merck (NYSE:MRK) and Pfizer (NYSE:PFE) have been neck and neck in the most recent coronavirus race: the race to develop a pill to fight the virus. Pfizer has drawn a lot of attention due to its leadership in the coronavirus vaccine market. The idea has been this: If Pfizer brings the first pill to market, the company can dominate in prevention and treatment.\nMerck may have burst that Pfizer dream last week though. Merck reported strong data from trials of its investigational covid pill -- and said it would request emergency authorization as soon as possible. Pfizer said back in July it would report data from its trial in the fourth quarter. Of course, that could be at any point as of now. Still, it's clear Merck is a step ahead from a timeline perspective. Let's take a closer look at what this means for Pfizer and its shareholders.\n\nImage source: Getty Images.\nThe covid treatment market\nFirst, a quick look at the treatment market. Right now, options are limited. The U.S. Food and Drug Administration has approved Gilead Sciences' Veklury (remdesivir) -- an antiviral administered to hospitalized patients through infusion. And the regulatory agency has authorized monoclonal antibody treatments. These are meant for at-risk individuals with mild-to-moderate illness. They're given through infusion in a healthcare setting.\nSo far, though, there hasn't been a pill option that people can take on their own. Several companies are working on possibilities. But Merck and Pfizer have remained at the head of the pack. At least when it comes to timing.\nA pill could be a game-changer. That's because it can be administered quickly and easily outside of a healthcare setting. People may be more likely to agree to take a pill at home than to make an appointment for an infusion. A pill also is a game-changer because it may halt the illness before it wreaks havoc. And that means fewer people will end up in the hospital.\nPills also offer a storage advantage. It's much easier for countries to stockpile pills than products needing more space or specific temperatures.\nPeak sales of $5 billion\nSo, it's clear pills could be big. SVB Leerink analyst Daina Graybosch predicts the Merck pill -- molnupiravir -- could generate peak annual sales of about $5 billion next year, according to Stat News. But does this first-to-market position mean bad news for Pfizer? Not necessarily.\nOf course, it's ideal to be first to market. If your product works well, it's likely people will stick with it. But, as we've seen with the coronavirus vaccine market, there is room for more than one player. I think this will be the case in the treatment market as well. First, there's the idea of production and delivery. One company will have difficulty supplying the entire world.\nSecond, there's the idea of product profile and efficacy. Merck's molnupiravir trips up the virus' ability to replicate properly. That's why it must be given within the first few days of infection -- before extensive replication has happened. Pfizer's investigational pill also blocks viral replication and must be given early on. But it works in a different way than molnupiravir. It stops protease enzymes from doing their job. Potentially, doctors may decide that one of the drugs is better for some patients and the other is best for other patients. Or studies may show positive results when combining the treatments.\nMolnupiravir reduced the risk of hospitalization or death by 50% compared with placebo in phase 3 trials. This is very positive. But we don't yet have Pfizer's data. If Pfizer results are about the same, it's likely the companies can share the treatment market. However, if Pfizer's results are much better or not as good, the whole picture could change.\nWhat does this mean for Pfizer investors?\nSo, what does this mean for Pfizer and its investors? Pfizer won't lose out if it makes it to market after Merck. What will determine Pfizer's market share potential will be the data. It's important for Pfizer investors to keep an eye on that news -- and eventually compare the Pfizer results to those of Merck's investigational pill.\nIn any case, though, Pfizer investors shouldn't worry. The company leads the global coronavirus vaccine market. Including the coronavirus vaccine, Pfizer sells eight blockbuster products and has 100 projects in the pipeline. Dominance in the coronavirus pill market would be great. But if it doesn't happen, there are still plenty of reasons to hang onto this pharmaceutical stock for the long term.","news_type":1,"symbols_score_info":{"MRK":0.9,"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":2273,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":820518075,"gmtCreate":1633401505603,"gmtModify":1633401505724,"author":{"id":"4094203859093810","authorId":"4094203859093810","name":"lih","avatar":"https://static.tigerbbs.com/71ace79439d0a5f0966a7046aa609708","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094203859093810","authorIdStr":"4094203859093810"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/820518075","repostId":"1121300578","repostType":4,"isVote":1,"tweetType":1,"viewCount":2207,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":601902855,"gmtCreate":1638468538277,"gmtModify":1638468538341,"author":{"id":"4094203859093810","authorId":"4094203859093810","name":"lih","avatar":"https://static.tigerbbs.com/71ace79439d0a5f0966a7046aa609708","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094203859093810","authorIdStr":"4094203859093810"},"themes":[],"htmlText":"ok","listText":"ok","text":"ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/601902855","repostId":"601017850","repostType":1,"repost":{"id":601017850,"gmtCreate":1638459363567,"gmtModify":1638494959903,"author":{"id":"3574968450404111","authorId":"3574968450404111","name":"B.God","avatar":"https://static.tigerbbs.com/8fba96cdefc2640a0413c00996aed28d","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574968450404111","authorIdStr":"3574968450404111"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BB\">$BlackBerry(BB)$</a>Institutions flushed out the weak idiot hands and stole their shares cheap after these weak idiots cut loss yesterday. 🤡","listText":"<a href=\"https://laohu8.com/S/BB\">$BlackBerry(BB)$</a>Institutions flushed out the weak idiot hands and stole their shares cheap after these weak idiots cut loss yesterday. 🤡","text":"$BlackBerry(BB)$Institutions flushed out the weak idiot hands and stole their shares cheap after these weak idiots cut loss yesterday. 🤡","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/601017850","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":1,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":961,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}